Drug recall · October 6, 2021
ceFAZolin 3 G in 0.9% Sodium Chloride recall
Why: Lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1
- Lots / codes
Lot, expiry: 20210722CEF-2, exp 09/20/2021; 20210728CEF-1, exp 09/26/2021
- Quantity
- 589 bags
- Company
- IntegraDose Compounding Services LLC, Minneapolis, MN
- Distribution
- NH, MA, MN
- Initiated
- September 17, 2021 · Voluntary: Firm initiated
- Classified
- September 30, 2021
- Reported
- October 6, 2021
- Ended
- October 2, 2022
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefazolin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.